Differential expression of somatostatin receptors in medulloblastoma

Journal of Neuro-Oncology

Volumn 51, Issue 2, 2001, Pages 93-103

  Guyotat, Jacques ^a   Champier, Jacques ^b   Saint Pierre, Ghislaine ^a   Jouvet, Anne ^a   Bret, Philippe ^a   Brisson, Christine ^b   Belin, Marie France ^b   Signorelli, Francesco ^a   Fevre Montange, Michelle ^b  

^a HÔPITAL NEUROLOGIQUE   (France)

^b INSERM   (France)

Author keywords

Medulloblastoma; Receptor; Somatostatin

Indexed keywords

ANTINEOPLASTIC AGENT; MESSENGER RNA; SOMATOSTATIN RECEPTOR;

ADULT; AMPLIFIER; ARTICLE; BRAIN VEIN; CANCER CELL; CANCER THERAPY; CELL LEVEL; CELL MEMBRANE; CHILD; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCHEMISTRY; MALE; MEDULLOBLASTOMA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SOUTHERN BLOTTING; STAINING;

CEREBELLAR NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MEDULLOBLASTOMA; MEMBRANE PROTEINS; RECEPTORS, SOMATOSTATIN; RNA, MESSENGER;

EID: 0035038952     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010624702443     Document Type: Article

References (39)

1. Patel YC: Somatostatin and its receptor family. Frontiers Neuroendo 20: 157-198, 1999
2. Pollak MN, Schally AV: Mechanisms of antineoplastic action of somatostatin analogs. Proc Soc Exp Biol Med 217: 143-152, 1998
3. Reisine T, BELL GI: Molecular biology of somatostatin receptors. Endocr Rev 16: 427-442, 1995
4. Schindler M, Holloway S, Humphrey PPA, Waldvogel H, Faull RLM, Berger W, Emson PC: Localization of the somatostatin SST2A receptor in human cerebral cortex, hippocampus and cerebellum. Neuro Report 9: 521-525, 1998
5. Thoss VS, Perez J, Probat A, Hoyer D: Expression of five somatostatin receptor mRNAs in the human brain and pituitary. Arch Pharmacol 354: 411-419, 1996
6. Reubi JC, Maurer R, Von Werder K, Torhorst J, Klijn JGM, Lamberts SWJ: Somatostatin receptors in human endocrine tumors. Cancer Res 47: 551-558, 1987
7. Schaer JC, Waser B, Mengod G, Reubi JC: Somatostatin receptor subtypes SST1, SST2, SST3 and SST5 expression in human pituitary, gastroenteropancreatic and mammary tumors. Comparison of mRNA analysis with receptor autoradiography. Int J Cancer 70: 530-537, 1997
8. Vikic-Topic S, Reisch KP, Kvols LK, Vuk-Pavlovic S: Expression of somatostatin receptor subtypes in breast carcinoma, carcinoid tumor, and renal cell carcinoma. J Clin Endocrinol Metab 80: 2974, 1995
9. Reubi JC, Waser B, Schaer JC, Marwalder R: Somatostatin receptors in human prostate and prostate cancer. J Clin Endocrinol Metab 80: 2806-2814, 1995
10. Buscail L, Saint-Laurent N, Chastre E, Vaillant JC, Gespach C, Capella G, Kalthoff H, Lluis F, Vaysse N, Susini C: Loss of SST2 somatostatin receptor gene expression in human pancreatic and colorectal cancer. Cancer Res 56: 1823-1827, 1996
11. Dutour A, Kumar U, Panetta R, Ouafik L, Fina F, Sasi R, Patel YC: Expression of somatostatin receptor subtypes in human brain tumors. Int J Cancer 76: 620-627, 1998
12. Reubi JC, Lang W, Maurer R, Koper JW, Lamberts SWJ: Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system. Cancer Res 47: 5758-5764, 1987
13. Reubi JC, Schaer JC, Waser B, Mengod G: Expression and localization of somatostatin receptor SSTR1, SSTR2 and SSTR3 messenger RNAs in primary human tumors using in situ hybridization. Cancer Res 54: 3455-3459, 1994
14. Feindt J, Becker I, Blomer U, Hugo HH, Mehdorn HM, Krisch B, Mentlein R: Expression of somatostatin receptor subtypes in cultured astrocytes and gliomas. J Neurochem 65: 1997-2005, 1995
15. Lamszus K, Meyerhof W, Westphal M: Somatostatin and somatostatin receptors in the diagnosis and treatment of gliomas. J Neuro-Oncol 35: 353-364, 1997
16. Fruhwald MC, O'Dorisio MS, Pietsch T, Reubi JC: High expression of somatostatin receptor subtype 2 (SST2) in medulloblastoma: implications for diagnosis and therapy. Pediat Res 45: 697-708, 1999
17. Muller HL, Fruhwald MC, Scheubeck M, Rendl J, Warmuth-Metz M, Sorensen N, Kuhl J, Reubi JC: A possible role for somatostatin receptor scintigraphy in the diagnosis and follow-up of children with medulloblastoma. J Neuro-Oncol 38: 27-40, 1998
18. Chomczynsky P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987
19. Yamada Y, Post SR, Wang K, Tager HS, Bell GI, Sein S: Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc Natl Acad Sci USA 89: 251-255, 1992
20. Corness JD, Demchyshyn LL, Seeman P, Van Tol HHM, Srikant CB, Kent G, Patel YC, Niznik HB: A human somatostatin receptor (SSTR3), located on chromosome 22, dysplays preferential affinity for somatostatin-14 like peptides. Febs Lett 321: 279-284, 1993
21. Yamada Y, Kagimoto S, Kubota A, Yasuda K, Masuda K, Someya Y, Ihara Y, Li Q, Imura H, Seino S, Seino Y: Cloning, functional expression and pharmacological characterization of a fourth (h SSTR5) and a fifth (h SSTR4) human somatostatin receptor subtype. Bioch Bioph Res Com 195: 844-852, 1993
22. Schulz S, Schmitt J, Wiborny D, Schmidt H, Olbricht S, Weise W, Roessner A, Gramsch C, Hollt V: Immunocytochemical detection of somatostatin receptors SST1, SST2A, SST2B and SST3 in paraffin-embedded breast cancer tissue using subtype-specific antibodies. Clin Canc Res 4: 2047-2052, 1998
23. Patel YC, Greenwood MT, Panetta R, Hukovic N, Grigorakis S, Robertson LA, Srikant CB: Molecular biology of somatostatin receptor sub-types. Metabolism 45: 31, 1996
24. Vanetti M, Vogt G, Hollt V: The two isoforms of the moure SRIF receptor (mSSTR2A and mSSTR2B) differ in coupling efficiency to anedylate cyclase and in agonist-induced receptor desnsitization. Febs Lett 331: 260-266, 1993
25. Helboe L, Moller M, Novregaard L, Schiodt M, Stidensen DE: Developement of selective antibodies against the human somatostatin receptor subtypes SST1-SST5. Mol Brain Res 49: 82-88, 1997
26. Reubi JC, Kappeler A, Waser B, Schondrunn A, Laissue J: Immunohistochemical localization of somatostatin receptor SST2A in human pancreatic islets. J Clin Endo Meta 83: 3746-3749, 1998
27. Reubi JC, Kappeler A, Waser B, Laissue J, Hipkin RW, Schonbrunn A: Immunohistochemical localization of somatostatin receptors SST2A in human tumors. Am J Path 153: 233-245, 1998
28. Denzler B, Reubi JC: Expression of somatostatin receptors in peritumoral veins of human tumors. Cancer 85: 188-198, 1999
29. Rorke LB, Trojanowski JQ, Lee VMY, Zimmerman RA, Sutton LN, Biegel JA, Goldwein JW, Packer RJ: Primitive neuroectodermal tumors of the central nervous system. Brain Path 7: 765-784, 1997
30. Viollet C, Bodenant C, Prunotto C, Roosterman D, Schaefer J, Meyerhof W, Epelbaum J, Vaudry H, Leroux P: Differential expression of multiple somatostatin receptors in the rat cerebellum during development. J Neurochem 68: 2263-2272, 1997
31. Qualman SI, O'Donsio MS, Fleshman DJ, Labanowski J, Shimada H, O'Dorisio TM: Neuroblastoma: correlation of neuropeptide expression in tumor tissue with other prognostic factors. Cancer 70: 2005-2012, 1992
32. Giordana MT, Schiffer P, Schiffer D: Prognostic factors in medulloblastoma. Child's Nerv Syst 14: 256-262, 1998
33. Steinbok P, Hentschel S, Cochrane DD, Kestle JR: Value of postoperative surveillance imaging in the management of children with some common brain tumors. J Neurosurg 84: 726-732, 1996
34. 111In-Pentetreotide. Anticancer Res 17: 1593-1598, 1997
35. Schmidt M, Scheidhauer K, Luyken C, Voth E, Hildebrandt G, Klug N, Schicha H: Somatostatin receptor imaging in intracranial tumours. Eur J Nuc Med 25: 675-686, 1998
36. Feindt J, Mentlein R, Krisch B: Time-dependent influence of the somatostatin analogue octreotide on the proliferation of rat astrocytes and glioma cells. Brain Res 746: 309-313, 1997
37. Lamberts SW, Van Der Lely A, Deherder WW, Hofland LJ: Drug therapy: octreotide. New Eng J Med 334: 246-254, 1996
38. Kahan Z, Nagy A, Schally AV, Hebert F, Sun B, Groot K, Halmos G: Inhibition of growth of MX-1, MCF-7-MIII and MDA-MB-231 human breast cancer xenografts after administration of targeted cytotoxic analog of somatostatin, AN-238. Int J Cancer 82: 592-598, 1999
39. 3-octreotide (DOTATOC): a pilot study in human gliomas. Clin Canc Res 5: 1025-1033, 1999